Thermal Partial Prostate Ablation for Intermediate- and High-risk Prostate Cancer: Con

被引：1
|
作者：
Gaffney, Christopher D. [1 ]
Ehdaie, Behfar [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA
来源：
EUROPEAN UROLOGY FOCUS | 2023年 / 9卷 / 04期
关键词：
PARTIAL GLAND ABLATION; RADICAL PROSTATECTOMY; FOCUSED ULTRASOUND; FOCAL THERAPY; OUTCOMES;
D O I：
10.1016/j.euf.2022.12.009
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [1] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [2] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [3] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [4] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [5] Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Zumsteg, Zachary S.
    Zelefsky, Michael J.
    Woo, Kaitlin M.
    Spratt, Daniel E.
    Kollmeier, Marisa A.
    McBride, Sean
    Pei, Xin
    Sandler, Howard M.
    Zhang, Zhigang
    BJU INTERNATIONAL, 2017, 120 (5B) : E87 - E95
  • [6] Value of PHI and PHID in the detection of intermediate- and high-risk prostate cancer
    Filella, Xavier
    Foj, Laura
    Wijngaard, Robin
    Luque, Pilar
    CLINICA CHIMICA ACTA, 2022, 531 : 277 - 282
  • [7] Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
    Chicas-Sett, R.
    Celada, F.
    Burgos, J.
    Farga, D.
    Perez-Calatayud, M.
    Roldan, S.
    Collado, E.
    Ibanez, B.
    Perez-Calatayud, J.
    Tormo, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S380 - S381
  • [8] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
    Raben, David
    Lucia, Scott
    Glode, Michael
    Crawford, E. David
    Kavanagh, Brian
    Raben, Adam
    Ayres, Jennifer
    ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110
  • [9] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer
    Loblaw, Andrew
    CANCER JOURNAL, 2020, 26 (01): : 38 - 42
  • [10] Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
    Yuh, Bertram E.
    Ruel, Nora H.
    Mejia, Rosa
    Wilson, Chelsea M.
    Wilson, Timothy G.
    EUROPEAN UROLOGY, 2012, 61 (05) : 1004 - 1010
12345